In the emerging field of digital pathology, Aleksandra Zuraw, DVM, Ph.D., DACVP, is one of the most prominent voices. Her journey to this position, however, was far from straightforward. When Zuraw was 12, she dreamed of becoming a veterinarian, picturing herself following in the footsteps of the British veterinary surgeon James Herriot, tending to “All Creatures…
How digital pathology can help drug developers address the forked road in oncology and beyond
Digital pathology is disrupting the drug development process, replacing traditional microscopy rooted in Victorian Era approaches with high-resolution images and AI-powered analysis tools. In a recent editorial webinar, industry experts Nathan Buchbinder (chief strategy officer at Proscia), Dr. John Cochran (chief medical officer and chief pathologist at Q² Solutions, an IQVIA subsidiary), and Dr. Monika…
How digital pathology can transform the value of clinical trial information
The field of pathology is gradually going digital, marking a pronounced shift from the traditional use of glass slides, a practice that dates back to the Victorian era. Digital pathology uptake reached an “exponential” pace in the wake of the pandemic, noted Dr. Monika Lamba Saini, pathologist-scientist, director of digital innovation at Q2 Solutions, an…
The growing influence of digital pathology in preclinical R&D: Spotlight on Proscia’s Concentriq
As drug discovery evolves, digital pathology platforms are playing a vital role in streamlining preclinical R&D processes and accelerating drug discovery. Proscia‘s Concentriq for Research reflects this trend. Earlier this year, we profiled PathAI’s AISight, a digital pathology platform designed to support AI-driven research. To learn more about Proscia’s digital pathology technology, we caught up with…